DXCM Q4 2017 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$221M+29.1% YoY

Gross Profit

$154M69.5% margin

Operating Income

$12M5.4% margin

Net Income

-$9M-4.3% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+19.7%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

$24M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$904M

Total Liabilities

$485M

Stockholders' Equity

$419M

Cash & Equivalents

$442M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$221M	$171M	+29.1%
Gross Profit	$154M	$117M	+31.5%
Operating Income	$12M	-$6M	+296.7%
Net Income	-$9M	-$7M	-27.0%